Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers
Completed · Not applicable
Conditions studied: Smoking Cessation
In brief
Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.
Key facts
- Study ID
- NCT05447897
- Run by
- University of Colorado, Denver
- People needed
- 9
- Starts
- 2022-12-01
- Expected to finish
- 2023-05-31
- Last updated by the study team
- 2024-04-16
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- FQHC implementation team including staff in the intervention FQHCs and their lung screening partners
You may not qualify if…
- FQHC staff or partners who leave the organization before end of study
Where it is running
- Massacusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.